2025 年 5 月 6 日 – 安森美(onsemi，美国纳斯达克股票代号：ON)公布其2025年第一季度业绩，要点如下：

第一季度收入为 14.457亿美元

第一季度公认会计原则(以下简称“GAAP”) 和 非GAAP 毛利率分别为 20.3%和40.0%

第一季度GAAP 营业利润率和非GAAP营业利润率分别为 (39.7)%和18.3%

第一季度GAAP 每股摊薄收益为 (1.15)美元，非GAAP 每股摊薄收益为 0.55 美元

运营现金流为6.02亿美元，自由现金流为4.55亿美元，同比增长72%，占收入的31%

“安森美第一季度的业绩体现了公司在此次经济低迷时期始终坚持的严谨策略——管理成本结构、合理优化制造布局并调整产品组合——成功实现了自由现金流的持续增长。我们致力于创造长期价值，加速向股东返还资本，同时投资于未来增长，”安森美总裁兼CEO Hassane El-Khoury说，“凭借行业领先的产品性能优势，安森美的设计获单势头依然强劲，已与全球各终端市场的头部客户达成了关键合作。”

下表概列2025年第一季度与可比较时期的部分财务业绩（未经审计）:

收入汇总

(百万美元)

(未经审计)

2025年第二季度展望

下表概列安森美预计2025年第二季度的GAAP及非GAAP展望：

* Diluted shares outstanding can vary as a result of, among other things, the vesting of restricted stock units, the incremental dilutive shares from the convertible notes, and the repurchase or the issuance of stock or convertible notes or the sale of treasury shares. In periods when the quarterly average stock price per share exceeds $52.97 for the 0% Notes, and $103.87 for the 0.50% Notes, the non-GAAP diluted share count and non-GAAP net income per share include the anti-dilutive impact of the hedge transactions entered concurrently with the 0% Notes, and the 0.50% Notes, respectively. At an average stock price per share between $52.97 and $74.34 for the 0% Notes, and $103.87 and $156.78 for the 0.50% Notes, the hedging activity offsets the potentially dilutive effect of the 0% Notes, and the 0.50% Notes, respectively. In periods when the quarterly average stock price exceeds $74.34 for the 0% Notes, and $156.78 for the 0.50% Notes, the dilutive impact of the warrants issued concurrently with such notes is included in the diluted shares outstanding. GAAP and non-GAAP diluted share counts are based on either the previous quarter's average stock price or the stock price as of the last day of the previous quarter, whichever is higher.

** Special items may include: amortization of acquisition-related intangibles; expensing of appraised inventory fair market value step-up; restructuring-related cost of revenue charges; non-recurring facility costs; in-process research and development expenses; restructuring, asset impairments and other, net; goodwill impairment charges; gains and losses on debt prepayment; actuarial (gains) losses on pension plans and other pension benefits; and certain other special items, as necessary. These special items are out of our control and could change significantly from period to period. As a result, we are not able to reasonably estimate and separately present the individual impact or probable significance of these special items, and we are similarly unable to provide a reconciliation of the non-GAAP measures. The reconciliation that is unavailable would include a forward-looking income statement, balance sheet and statement of cash flows in accordance with GAAP. For this reason, we use a projected range of the aggregate amount of special items in order to calculate our projected non-GAAP operating expense outlook.